Drupal.behaviors.print = function(context) {window.print();window.close();}>
Cornell Study Shows Targeted Sequencing Can ID Mutations in Advanced Prostate Cancer FFPE Samples
September 19, 2012
Cornell Study Shows Targeted Sequencing Can ID Mutations in Advanced Prostate Cancer FFPE Samples
By
Molika Ashford
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail
Molika Ashford
.
Related Stories
Anticipating NY Approval, Good Start Expands Sequencing-Based Carrier Screening Panel to 23 Diseases
October 24, 2012 / Clinical Sequencing News
Startup Parabase Genomics Targets Late 2013 Launch for Targeted Sequencing Neonatal Test
October 17, 2012 / Clinical Sequencing News
EdgeBio to Offer Clinical Exome Sequencing to Labs and Hospitals for in-House Interpretation
May 2, 2012 / Clinical Sequencing News
Cynvenio Offering NGS Analysis of Isolated Circulating Tumor Cells Using AmpliSeq Panel
April 10, 2013 / Clinical Sequencing News
UW-OncoPlex Cancer Sequencing Service Combines Hotspot Detection, Exon Analysis
February 27, 2013 / Clinical Sequencing News